FindTrial
Sign In

Building and prediction of the heterogeneity in pancreatic neuroendocrine neoplasms based on Radio-pathomics

Building and prediction of the heterogeneity in pancreatic neuroendocrine neoplasms based on Radio-pathomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090898
Enrollment
Unknown
Registered
2024-10-15
Start date
2024-01-19
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic neuroendocrine neoplasm

Interventions

Training group :none
Validation group :none

Sponsors

Changhai Hospital, The Navy Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1.patients who underwent radical surgery in Shanghai Changhai Hospital and 411 Hospital were pathologically confirmed to have pancreatic neuroendocrine neoplasms after surgery; 2.Pathological and clinical data are complete. 3.standard contrast-enhanced CT of the pancreas were performed within 1 month before surgery.

Exclusion criteria

Exclusion criteria: 1.poor quality of pathological images that precludes evaluation; 2.merge with other malignant tumors; 3.lost to follow-up. 4. poor CT image quality or small lesions that cannot be delineated

Design outcomes

Primary

MeasureTime frame
Recurrence free survival, RFS;radiomics and pathomics features;—

Countries

China

Contacts

Public ContactYun Bian

Changhai Hospital, The Navy Military Medical University

bianyun2012@foxmail.com+86 138 1635 7024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026